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Background: Calcium channel blockers belonging to the dihydropyridine family have been used as a potent
arterial vasodilator in the management of angina and cardiovascular diseases. In the design of glassy carbon
electrode coatings for the study of the same, multiwall carbon nanotubes (MWCNT) are favored. They are known
for the reduction and oxidation of electroactive species towards cathodic and anodic direction with the
simultaneous enhancement of the peak current.
Results: The MWCNT-modified glassy carbon electrode exhibited a sharp anodic peak potential at around at 0.5 V
for amlodipine (AMLD) andnimodipine (NIMD), and 0.4 V for felodipine (FELD) in the cyclic voltammograms. The
antihypertensive drugs were determined using a simple two-step procedure developed which comprised a
preconcentration step followed by the differential pulse stripping voltammetric quantification. Concentration
calibrations were linear within the range from 0.01 to 0.3 μg/mL for AMLD and FELD, and 0.025 to 0.3 μg/mL
for NIMD.
Conclusion: The lower limit detection (LOD) was found to be very low on modified electrode. The LOD is 0.005
μg/mL for AMLD and FELD, and 0.01 μg/mL for NIMD. The prepared electrode showed an excellent electrocatalytic
activity towards the oxidation of antihypertensive drugs leading to a remarked improvement in sensitivity. An
electrochemical sensor featuring the MWCNT-modified electrode was applied successfully as the result for the
calcium channel blocker determination in pharmaceutical samples.
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Calcium channel blocker belonging to the dihydropyridine
family has commonly been used as a potent arterial vaso-
dilator in the management of angina and cardiovascular
diseases [1]. Electrochemistry plays an important role to
study the formation of radical and its reactivity in one-pot
systems [2,3]. There are several reports in literature con-
cerning the development of stable carbon nanotube
(CNT)-based electrodes for environmental samples, elec-
trochemical sensors, electrocatalysis, and electrochemical
estimation of drugs and compounds of biological interest* Correspondence: pms11@rediffmail.com
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in any medium, provided the original work is p[4,5]. However, simple but effective method for the devel-
opment of homogeneously and stably assembled CNT-
based electrode is particularly desired for electroanalytical
determinations. Multiwall carbon nanotube (MWCNT)-
based electrodes were prepared generally by casting
MWCNT suspension on conventional electrode surface
[6,7]. The resulting electrodes have been successfully uti-
lized in the sensitive detection of various biological mole-
cules such as uric acid [4], folic acid [6], and cytochrome c
[7]. Generally, MWCNT-based electrodes enhance the de-
tection sensitivity and improve reversibility as they can pro-
mote electron transfer [8].
Amlodipine besylate is a dihydropyridine derivative
with calcium antagonist activity [9]. The main metabolic
pathway is oxidation of dihydropyridine ring to the pyri-
dine analog [10]. Amlodipine (AMLD) has side effects
such as peripheral edema (often), dizziness, palpitations,is an Open Access article distributed under the terms of the Creative Commons

































Scheme 1 Calcium channel blocker drugs.
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http://www.industchem.com/content/3/1/29muscle-, stomach- or headache, dyspepsia, nausea (very
often), blood disorders, development of breasts in men
(gynecomastia), impotence, depression, insomnia, tachycar-
dia, and gingival enlargement (sometimes). The amlodipine
besylate in tablets and biological fluids was determined
using chromatographic techniques such as gas chromatog-
raphy (GC) [11], liquid chromatography (LC) [12], and high
performance thin layer chromatography [13]. Chromato-
graphic methods offer a high degree of selectivity but need
sample clean-up and relatively heavy instrumentation. Few
spectrophotometric methods have been reported for amlo-
dipine besylate determination [14]. A differential pulse
voltammetric method has been described for the determin-
ation of amlodipine besylate in tablets at pH 5.5 [15]. The
electrochemical behavior at the dropping mercury and
glassy carbon electrodes (GCE) of some calcium antagonist
drugs has been reported [16].
Nimodipine (NIMB), a dihydropyridine calcium channel
antagonist, has potent vasodilatory effect on cerebral ves-
sels and increases cerebral blood flow. Nimodipine, in high
doses (2 to 10 mg/kg), has been shown to improve mem-
ory retention and/or memory recall process in aged rats.











Figure 1 Plot of peak potential vs. pH.effects into groups based on dose levels given every 4 h.
For the high dosage group (90 mg), less than 1% of the
group experienced adverse conditions including itching,
gastrointestinal hemorrhage, thrombocytopenia, neuro-
logical deterioration, vomiting, diaphoresis, congestive
heart failure, hyponatremia, decreasing platelet count,
disseminated intravascular coagulation, and deep vein
thrombosis. The electrochemical reduction of 4-nitrophe-
nyl-1,4-dihydropyridine compounds such as nifedipine,
nitrendipine, nimodipine, nicardipine, and furnidipine in
protic media [17] follows the general pattern of nitroaro-
matic compounds involving a single four-electron step
producing the hydroxylamine derivative. However, the
electrochemical reduction of nitrendipine, nimodipine,
and nifedipine in mixed aqueous-DMF media resulted in
the generation of the one-electron reduction product, the
nitro radical anion [18].
Cyclic voltammetry was also performed on insulin, val-
sartan, and felodipine (FELD) separately with the potential
window applied from −0.5 V to +1.00 V vs. Ag/AgCl. Infu-
sion of valsartan and felodipine has been reported to lower
the striatum glucose level significantly [19]. Stereospecific
determination of nimodipine was reported using an
ES-OVM column with detection at 230 nm, resulting in a
high specific separation of enantiomers with a limit ofFigure 2 Plot of peak current vs. pH.
Figure 3 Plot of peak current vs. square root of scan rate. Figure 4 Plot of log peak current vs. log scan rate.
Sikkander et al. International Journal of Industrial Chemistry 2012, 3:29 Page 3 of 8
http://www.industchem.com/content/3/1/29quantitation for each enantiomer of about 1 ng/ml from 1-
ml plasma [20]. The stability of the retention volumes of
the enantiomers of nimodipine by LC has been checked to
guarantee the reproducibility of enantiomer collection to
allow automated LC analysis [21]. Introduction of felodi-
pine as an enantioselective determination method for felo-
dipine in human plasma has been described involving
off-line detection using capillary GC on a DB-1 column
with ECD following chiral separation on a Chiralcel OJ col-
umn (Chiral Technologies, Illkirch, France) monitored at
240 nm [22]. Quantitation limits of 0.1 ng/ml were demon-
strated for a sample size of 0.5-ml biological fluid, while
felodipine [23] and nisoldipine [24] were finally determined
by GC-MS in PEI mode [25].
Until now, no publications concerning the electroanalyti-
cal determination of antihypertensive drugs in pharmaceut-
ical formulations are available in the literatures. Therefore,
the aim of the present investigation is to investigate the
electrochemical behavior of antihypertensive drugs on
MWCNT-modified GCE and to develop sensitive stripping
voltammetric methods for their determination.
Methods
Electrochemical workstation (760C model, CH Instru-
ments, TX, USA) was employed mainly for carrying out
electroanalytical studies. The three calcium channel blocker
drugs of amlodipine, felodipine, and nimodipine (Scheme 1)
were received from CIPLA Ltd, Mumbai, India and used
as such.
The stock solutions were made up in methanol/double
distilled purified water (TKA-LAB, Thermo Electron LED
GmbH, Germany) (80:20). For studies in aqueous metha-
nol media, Britton-Robinson buffers, 4.0, 7.0, 9.2, and 0.1
moldm−3 KOH, and 0.1 mol dm−3 H2SO4 were used as the
media for the analysis. Multiwall CNT produced by arc
method was purchased from Sigma-Aldrich (MO, USA)
and sodium dodecyl sulfate (SDS) from Merck (Merck &
Co., Inc, NJ, USA).
Purging of nitrogen was done for analyte solution
placed in the electrochemical cell of 15-ml capacity for25 min under stirring, and then voltammograms were
recorded while blanketing nitrogen gas. To get reprodu-
cible results, great care was taken in the electrode pre-
treatment. The GCE was pretreated in two ways as
described earlier [26].
Preparation of MWCNT-modified GCE
One milligram MWCNT was dispersed in 1 mL of 0.1
M sodium dodecyl sulfate using an ultrasonicator to give
black suspensions [27]. Cast films were prepared by pla-
cing 5 μL of the MWCNT/surfactant suspensions on
GCE and then evaporating them in an oven at 50°C.
Results and discussion
In the experiments carried out for the effect of pH, pH
13.0 was chosen as the best for further electrochemical
studies. In the case of experiments on the influence of
modifier, the ip and the Ep values are presented in
Figures 1 and 2. As it is observed, the MWCNT-
modified electrode gives higher peak intensity values for
all the pharmaceuticals. The modifier also influences the
Ep values, although the shifts caused in the peaks of the
analytes are not significantly relevant.
In the investigation of cyclic voltammetric behavior of
drugs, the peak potentials correlated well with log scan
rate and resulted in straight lines. The fractional ‘αn’
value calculated from the slope confirmed irreversible
electron transfer. The peak current showed an increasing
trend with sweep rate and straight lines with good cor-
relation coefficients, indicating adsorption. The plots, ip
vs. v1/2, were curve lines (Figure 3). The log peak current
vs. log scan rate showed straight line (Figure 4), and its
slope value is above 0.5. Thus, it is further confirmed
that adsorption of the substrate on the pores and surface
of the electrode and the overall reaction was adsorption-
controlled.
In the investigation of differential pulse stripping vol-
tammetric behavior of drugs, maximum peak current
was observed for AMLD, FELD, and NIMD at 30, 20,
and 10 s respectively. The decreased current above the
Figure 5 SEM photographs. (a) AMLD, (b) FELD, and (c) NIMD on MWCNT-modified GCE.
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saturation of the electrode surface and blocking of the
products formed on the surface. The accumulation of
the drugs on the modified electrode surface was ascer-
tained by carrying out SEM analysis.
SEM was employed to study the surface morphology of
the three accumulated drugs on MWCNT-coated glassy
carbon electrode. The stem-like structure of the coating
confirmed the presence of MWCNTs on GCE. The aver-
age tube size of the material is 50 nm as reported earlier by
us [27,28]. The drug AMLD was adsorbed on MWCNT
electrode during the accumulation and exhibited granular
sponge-like structure (Figure 5a). FELD exhibited broken
pitch and sponge-like structure (Figure 5b), and NIMD
exhibited tide sponge-like structure (Figure 5c). Different
surface morphology confirmed the accumulation of drugs
on the MWCNT/GCE.
The initial scan potential was also an important param-
eter in controlling both peak potential and peak height in
the stripping voltammogram. The initial potential was var-
ied between −0.4 to 0.2 V, and an initial scan potential
at −0.3 V for AMLD, −0.1 V for FELD, and 0 V for NIMD
led to higher peak current response. Pulse height was var-
ied between 0.025 and 0.25 V. This variation had shown a
decrease in peak current with increase in applied pulse
height after 0.05 V. Hence, pulse height of 0.05 V was
chosen due to increased current response for all drugs.
The effect of pulse period demonstrated that the strippingTable 1 Optimum experimental conditions in DPSV
Variable Range studied
AMLD FELD
pH 1 to13 1 to 13
Accumulation potential (V) 0 to 0.6 0 to 0.6
Accumulation time (s) 15 to 90 15 to 90
Initial scan potential (V) −0.2 to 0.3 −0.2 to 0.3
Pulse height (PH; mV) 25 to 150 25 to 150
Pulse width (PW; ms) 25 to 150 25 to 150
Scan increment (SI; mV) 2 to 20 2 to 20
Stirring rate (rpm) 50 to 250 50 to 250
Rest period (s) 2 to 10 2 to 10peak current increased up to 50 ms and then decreased
with an increase in pulse width from 75 to 125 ms for
three drugs. The peak current decreased with an increase
in pulse width from 25 to 100 ms, and a pulse width of 50
ms was selected. Thus, the maximum peak current condi-
tions were arrived at, and the results are presented in
Table 1. These conditions were used to study the effect of
concentration.
Analytical characteristics
Typical differential pulse stripping voltammograms for
AMLD, FELD, and NIMD obtained under the maximum
peak current experimental conditions were presented in
Figure 6. As the concentration of the drugs increased, the
stripping peak current increased. Calibration plots were
made and presented in Figure 7. The limits of concentra-
tion were 0.01 to 0.3 μg/mL for AMLD and FELD, and
0.025 to 0.3 μg/mL for NIMD. The LOD is 0.005 μg/mL
for AMLD and FELD, and 0.01 μg/mL for NIMD. The pre-
cision of the method was ascertained by measuring the
peak current of the drugs’ response in five standard sam-
ples. Ten replicates were analyzed, and standard deviations
were calculated. The relative standard deviation was 2.5%
for a concentration 50 μg/mL of AMLD, 2.7% for the same
concentration of FELD, and 3.1% for 50 μg/mL of NIMD.
The low value of standard deviation indicated good repro-
ducibility and feasibility of this method for the determin-
ation of drugs.Optimum value
NIMD AMLD FELD NIMD
1 to 13 13.0 13.0 13.0
0 to 0.6 0.3 0.4 0.3
15 to 90 15 30 30
−0.2 to 0.3 0.1 0.1 0
25 to 150 50 75 50
25 to 150 50 50 50
2 to 20 4 6 6
50 to 250 250 250 250
2 to 10 5 5 5
Figure 6 Differential pulse stripping voltammetry. DPSV of (a)
AMLD (b) FELD and (c) NIMD under optimum conditions on
MWCNT-modified GCE.
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AMLD on SWCNT/EPPGE and MWCNT/EPPGE for 1.0
× 10−9 mol L−1 and 5.0 × 10−9 mol L−1 [29], respectively,
0.025 μg mL−1 by spectrofluorimetric method was reported
[30]. Another compound of FELD was also reported: 0.3 to
1.5 μg cm−1 by AAS [31] and range studies of 1.0 to 40.0
μg/mL by spectrophotometric method [32].
Selectivity of electrode is very important. Among the
electrode system, the modified MWCNT is very sensitiv-
ity for all three drug compounds. Range studies are also
very low compared to those reported in the literature
since MWCNT was selected for the determination of
the drugs.
The reproducibility of electrode was also an important
parameter for electrochemical determination technique.
The MWCNT modified system is highly stable up toy(NIMD) = 27.692x + 0.638
R2 = 0.9736



















Figure 7 Calibration plot of peak current vs. concentration.100 cycles of experimental conditions. After the 100
cycles, the reproducibility decreased slowly. The number
of experiments continued from101to 200 cycles, and the
10% reproducibility decreased.Pharmaceutical sample analysis
In order to evaluate the applicability of the proposed
method, three commercial samples in combination or in
pure form containing anyone of AMLD, FELD, and
NIMD were selected. The pharmaceutical samples were
collected from medical shops at Karaikudi, Tamilnadu,
India. Various tablets having AMLD, FELD, and NIMD
were examined for the estimation of content of drugs.
The tablets were dissolved in methanol, and then the fil-
trate was further evaporated to get the drug in pure
form. The residue was dissolved in known quantity of
methanol and transferred into a 250-ml calibrated flask
and made up to the mark. A 10-ml portion of this solu-
tion was transferred into a 50-ml calibrated flask, and
0.1 mM NaOH containing 50% aqueous methanol was
used to dilute the contents of the flask to the required
volume. The standard addition method was used. An ali-
quot of 0.05 ml of the 0.1 μg/mL standard stock solution
was added to the solution prepared as described above.
Differential pulse stripping voltammetric studies under
the maximum current signal experimental conditions
were carried out and the trace amount of drugs in the
sample were determined. A relative standard deviation
of 2.9% was obtained for 0.1 μg/mL AMLD for ten iden-
tical measurements. The relative standard deviation of
2.9% was obtained for 0.1 μg/mL of FELD and NIMD
for ten identical measurements. Thus, the suitability of
this method for the determination of AMLD, FELD, andy(FELD) = 121.48x + 0.476
R2 = 0.9975
.15 0.2 0.25 0.3
 ( g/mL)
Table 2 Amount of drugs in tablets determined by DPSV in tablets
Brand name Company name Tablets (mg) Experimental value(mg) % RSD value
Amlodipine
Amace Systopic 5 4.80 2.1
Amlodac ZydusMedica 10 9.96 2.2
Amlopres Cipla 10 9.85 2.1
Myodura WOCKHARDT 10 9.90 2.2
Lama Stadmed 10 9.88 2.5
Card Jagsonpal 10 9.95 2.3
Calchek Ipca 10 9.94 2.7
Felodipine
Felogard Cipla 10 9.93 2.1
Plendil Astra Zeneca 10 9.90 2.4
Nimodipine
Nimodip USV 30 29.27 2.5
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sented in the Table 2.
Experimental
Effect of pH
Britton-Robinson buffer/acid/alkaline solution was
selected as the support electrolyte to find the optimal
pH values for every analyte. The range of pH investi-
gated was from 1.0 to 13.0. Values outside of this inter-
val did not give either oxidation or reduction waves.
Moreover, in some cases, signals were very close to the
discharging current of the background, making the
quantification very difficult. The pH affects both peak
potential (Ep) and peak intensity (ip) values. With re-
spect to the first parameter, Ep values for the three phar-
maceuticals decrease (or increase in absolute value) with
pH, being more positive (Figure 1). Figure 2 shows theFigure 8 Cyclic voltammogram. (a) 305 μg/mL amlodipine, (b) 190 μg/m
rate is 100 mV/s.dependence of ip with respect to pH for all the three
drugs. From the curves, the optimal pH values for every
one of them were deduced. This study was focused in
order to find particular zones of potential for every com-
pound that allowed the sequential determination of the
three pharmaceuticals in a unique biological sample.
Influence of modifier
ip and the Ep values using unmodified GCE and
MWCNT-modified carbon electrode were studied. The
modifier is expected to give to higher ip value and the
longest distance from the discharging current of the
background.
Cyclic voltammetric behavior of drugs
Cyclic voltammetric behavior of amlodipine, felodipine,
and nimodipine on MWCNT-modified GCE was carriedL felodipine, and (c) 210 μg/mL nimodipine on GCE at pH 13.0. Scan
Figure 9 Cyclic voltammogram. (a) 305 μg/mL amlodipine, (b) 190 μg/mL felodipine,(c) 210 μg/mL nimodipine, and (d) absence of drugs on
MWCNT/GCE at pH 13.0. Scan rate is 100 mV/s.
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tammograms recorded for all the three drugs on GCE
and modified glassy carbon electrode. They exhibited
one oxidation peak with larger current and one reduc-
tion peak with lesser current for modified GCE, but bare
GCE shows lower current and high potential difference
from modified electrode. The anodic peak was taken for
further discussion due its analytical characteristic be-
cause of larger peak current.
Differential pulse stripping voltammetry
Differential pulse stripping voltammetry (DPSV) experi-
ments were carried out to ascertain the best conditions
for the adsorption process. Many preconcentration-
stripping experiments were performed for different accu-
mulation potentials and at an accumulation time of 15 s
to evaluate the electrostatic attraction/repulsion between
electrode surface and the drugs. When accumulation po-
tential changed from −0.1 to +0.5 V, the maximum
responses were obtained at 0.1 V for all three drugs.
Maximum peak current was found for an accumulation
potential in the positive region at 0.1 V because of the
electrostatic interaction between the positive nature of
electrode at this potential and the electron-rich sub-
strate. After fixing the accumulation potential, the accu-
mulation time was varied between 10 to 60 s.
Conclusion
MWCNT-modified GCE allowed the successful deter-
mination of AMLD, FELD, and NIMD drugs with a de-
tection limit of 0.005 μg/mL for AMLD and FELD, and
0.01 μg/mL for NIMD. The anodic peak current varies
linearly under optimized conditions in the concentration
range from 0.01 to 0.3 μg/mL for AMLD and FELD, and
0.025 to 0.3 μg/mL for NIMD. The results obtained are
promising and demonstrate the utility of the developedmethod for the determination of drugs in pharmaceut-
ical formulations. The specificity of the voltammetric
method was also investigated in the presence of sub-
stances present in drugs. Thus, the present investigation
revealed that the proposed method is simple, specific,
sensitive, and effective for the determination of three
calcium channel blocker at MWCNT-modified glassy
carbon electrode in pharmaceutical formulations.
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